Private equity’s GTCR is selling Vernon Hills-based Antylia Scientific, a maker of molecular diagnostic reagents, specialty ...

Private equity firm GTCR has sold Antylia Scientific to Brookfield Asset Management ’s private equity business and Caisse de ...

Brookfield Asset Management and Caisse de depot et placement du Quebec have bought life-sciences company Antylia Scientific from private-equity firm GTCR for roughly $1.34 billion.

Brookfield Asset Management and CDPQ have acquired Antylia Scientific, a Vernon Hills, Illinois-based life sciences company, for about $1.34 billion. The seller was GTCR. Antylia is focused on the ...

GTCR is already on track to return a record $5 billion-plus to investors for a calendar year, people familiar with the matter ...

Private equity firm GTCR is set to return more than $5 billion to its investors in the calendar year, a source familiar with the matter told Reuters on Thursday, after a string of strong exits sealed ...

Private equity firm GTCR has reached an agreement to offload ITEL Laboratories (itel) to Nearmap, a portfolio company of ...

The capital influx is aimed at accelerating JMG's growth through acquisitions, talent development and platform investment.

Thoma Bravo-backed Nearmap has agreed to buy insurance technology provider itel from private equity firm GTCR, the companies ...

PE firm GTCR has confirmed its agreement to buy UK insurance broker JMG Group, alongside existing investor Synova. The announcement comes after this publication revealed yesterday that GTCR was ...

The private-equity firm GTCR has agreed to sell a big stake in Ultimus Fund Solutions that values the administrative-services provider at nearly $2 billion, according to people familiar with the ...